Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3134]

Precisely poking cells en masse to cure cancer

Precisely poking cells en masse to cure cancer

Mount Sinai researchers examine the metabolic effects of an oral blood cancer drug

Mount Sinai researchers examine the metabolic effects of an oral blood cancer drug

Lasting tumour regression of leukaemia and lymphoma in mouse models achieved by U-M compound

Lasting tumour regression of leukaemia and lymphoma in mouse models achieved by U-M compound

Early data for new drug combination to treat neuroblastoma

Early data for new drug combination to treat neuroblastoma

Learning to stop cancer at its roots

Learning to stop cancer at its roots

Ground-breaking trial of CRISPR-edited immune cells for cancer appears safe

Ground-breaking trial of CRISPR-edited immune cells for cancer appears safe

Blood cancers: New generation stem cell transplant significantly reduces complications for patients

Blood cancers: New generation stem cell transplant significantly reduces complications for patients

Clinical guide for the genomic diagnosis of Myelodysplastic Syndromes and Chronic Myelomonocytic leukaemia published

Clinical guide for the genomic diagnosis of Myelodysplastic Syndromes and Chronic Myelomonocytic leukaemia...

Chemotherapy sometimes sets the stage for drug-resistant leukaemia at relapse

Chemotherapy sometimes sets the stage for drug-resistant leukaemia at relapse

$Antibody-drug conjugate shows early promise in patients with relapsed/refractory B-cell non-hodgkin lymphoma$

Antibody-drug conjugate shows early promise in patients with relapsed/refractory B-cell non-hodgkin lymphoma

More from ecancer